Last update:

Oncology & Cancer news

Oncology & Cancer

Scientists zero in on cellular mechanism fueling drug-resistant cancers

The mystery of how cancers build up resistance mechanisms and evade the treatments that should have destroyed them is a hugely pressing question. Overcoming cancer treatment resistance—a phenomenon that contributes to as ...

Oncology & Cancer

Researchers develop novel antibody-RNA therapy for resistant cancers

A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models, according to a study reported ...

Oncology & Cancer

How metabolic chatter between cells undermines anti-tumor immunity

A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary metabolic processes, program one set of noncancerous cells to manipulate another set of such cells ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Oncology & Cancer

Trove of genetic data to spur cancer research released

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a pancreatic cancer cell. Scientists ...

Oncology & Cancer

Genetic changes control metastasis formation in colorectal cancer

Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e. secondary tumors—in other ...

Oncology & Cancer

Gut microbes may help in recognizing and treating pancreatic cancer

Pancreatic cancer is a severe illness and major challenge in cancer medicine since it is difficult to diagnose, while potential therapies are scarce. A new international cooperation study indicates that in the future pancreatic ...

Oncology & Cancer

The leading risk factor for cancer isn't what you think

If you were to ask most people what causes cancer, the answer would probably be smoking, alcohol, the sun, hair dye or some other avoidable element. But the most important risk factor for cancer is something else: aging. ...

Medications

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.

Oncology & Cancer

HPV can drive tumor development in rare nasal cancers

Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to a new comprehensive study of these tumors from investigators at the Johns Hopkins University School ...

Oncology & Cancer

Appendix cancer rising among younger generation: New study

Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought. For decades, it was the kind of disease that doctors might encounter only once or twice in a career, and it ...